A single dose of one osteoporosis medication may be enough to help patients — even those who are very frail.

Women with osteoporosis (brittle bones) have two effective treatment choices: Prolia (denosumab) and Reclast (zoledronic acid). So which is more effective? A recent study did a side-by-side comparison.

After menopause, many women need treatment for bone loss due to osteoporosis. But a medication that prevents bone loss may also have the side effect of inhibiting bone growth.

Past studies have raised concerns that a type of osteoporosis drug may boost the risk of unusual bone fractures. Now research suggests this risk may be overstated.

They're designed to strengthen bones. This class of drugs known as bisphosphorates is also prescribed to cancer patients to treat excessive calcium in the blood. These drugs can actually increase the risks of unusual bone fractures.